| 000 | 01680nam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223025941.0 | ||
| 008 | 091021s2009 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.08.M.Sc.2009.Am.P | ||
| 100 | 0 | _aAmal Anwar Taha | |
| 245 | 1 | 0 |
_aPharmaceutical study of polymorphic transformation of praziquantel / _cAmal Anwar Taha ; Supervised Ahmed Abdelbary , Mohamed A. Nafadi |
| 246 | 1 | 5 | _aدراسة صيدلية على تحول الشكل البلورى لعقار البرازيكوانتيل |
| 260 |
_aCairo : _bAmal Anwar Taha , _c2009 |
||
| 300 |
_a214 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutics | ||
| 520 | _aThe work in this thesis focused on two issues. The first issue is to study the effect of recrystallization of praziquantel (PZQ) from different solvents, and in the presence of different additives on PZQ crystal habit and detecting the possibility of appearance of new polymorphs. The second issue is to investigate the effect of the recrystallization process on solubility and dissolution characteristics of PZQ aiming to improve its bioavailability | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aPolymorphism | |
| 653 | 4 | _aPraziquantel | |
| 653 | 4 | _aRecrystallization | |
| 700 | 0 |
_aAhmed Abdelbary Abdelrahman , _eSupervisor |
|
| 700 | 0 |
_aMohamed Mahmoud Abdelfattah Nafadi , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c24193 _d24193 |
||